LANTING CAPITAL
Lanting Capital is a venture capital firm that focuses on healthcare industry and especially pharmaceuticals. LTC is founded by pharmaceutical veterans and asset management experts. Lan Ting Capital is a cross-border, pharmaceutical focused strategic consulting and investment firm. LTC leverages their unparalleled industry knowledge and network plus deep financial market know-how across the US, China and Europe to unlock unique cross-border growth opportunities for our portfolio companies and investors.
LANTING CAPITAL
Social Links:
Industry:
Financial Services Health Care
Status:
Active
Contact:
008657189182016
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Apple Mobile Web Clips Icon WordPress Nginx Euro DigiCert SSL Pound Sterling
Similar Organizations
Kaiwu Capital
Kaiwu Capital is a venture capital firm that focuses on TMT, clean-tech, healthcare, innovations, renewable energy, consumer, and education.
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-04-07 | Rona Therapeutics | Lanting Capital investment in Series A - Rona Therapeutics | 33 M USD |
| 2021-02-18 | Regor Therapeutics | Lanting Capital investment in Series B - Regor Therapeutics | 90 M USD |
| 2021-01-13 | Yunji Technology | Lanting Capital investment in Series C - Yunji Technology | 180 M CNY |
| 2020-12-31 | Immvira | Lanting Capital investment in Series C - Immvira | N/A |
| 2018-12-06 | Green Rice Technology | Lanting Capital investment in Series B - Green Rice Technology | 20 M USD |
| 2018-11-12 | DeepTech | Lanting Capital investment in Series A - DeepTech | N/A |
| 2018-02-28 | Kuandeng | Lanting Capital investment in Series A - Kuandeng | 100 M CNY |
| 2018-01-04 | Aqara | Lanting Capital investment in Series B - Aqara | 15 M USD |
| 2017-11-21 | Yunji Technology | Lanting Capital investment in Series A - Yunji Technology | N/A |
| 2017-10-12 | Motovis | Lanting Capital investment in Series A - Motovis | N/A |